Dr Lal Pathlabs

Medical testing boom: 3 stocks to watch as Thyrocare and Dr Lal declare bonus shares

Strong growth in medical testing has benefited leading pathological laboratory chains. And two leading chains have recently declared bonus issues.…

November 25, 2025 05:30 IST

India's diagnostic disruption: Why THESE companies are poised for growth amidst a chronic disease epidemic. ( This is an AI generated Image)

India’s “silent epidemic”: 2 diagnostic stocks to watch as lifestyle diseases surge

India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.

November 3, 2025 05:15 IST

2 Healthcare Stocks Flashing Bullish Signals. Add them to your watchlist?

While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…

Updated: September 1, 2025 09:05 IST

3 ‘Buy’ recommendation by Nuvama, with up to 52% upside potential

Nuvama recommends buying HUL, Dr Lal Pathlabs, and IndiaMart for up to 52% potential upside; explore their analysis for investment…

June 25, 2025 13:38 IST

Q4 Results: Companies like Maruti Suzuki India, RBL Bank, Hindustan Zinc, Dr Lal PathLabs, DCB Bank, are releasing Q4 results today.

Q4 Results Highlights: Shriram Finance profit up 9.95%, NII at Rs 5,565.5 cr; Maruti Suzuki profit drops by 1.04%

Q4 Results: Today, companies like Maruti Suzuki India, Tata Technologies, RBL Bank, Hindustan Zinc, Bank of Maharashtra, Dr Lal PathLabs,…

Updated: April 29, 2025 08:20 IST

Illumina to present updates on several key innovations in whole-genome sequencing at ASHG meeting

Dr. Lal Pathlabs redesignates Ved Prakash as Group CFO and CEO – International Business

Goel was instrumental in bringing the Company’s IPO in 2015 and led many small and mid-size M&A including a large…

August 13, 2024 12:02 IST

Dr Lal PathLabs, Dr Lal PathLabs Q2 results, profit, revenue, EBITDA, patients, expansion plans

Dr Lal PathLabs Q2 profit jumps 52.4% to Rs 109.30 crore, revenue rises by 12.6% on-year

Dr Lal PathLabs posted revenue from operations at Rs 601.30 crore, up 12.6 per cent as against Rs 533.80 crore…

November 2, 2023 14:53 IST

Dr Lal PathLabs Q1 profit rises by 43.2% to Rs 82.60 crore, revenue up 7.6%

Dr Lal PathLabs posted revenue from operations at Rs 541 crore, up 7.6 per cent in comparison to Rs 502.70…

July 27, 2023 15:52 IST

Dr Lal PathLabs Q4 net profit falls 8 pc to Rs 57 crore

Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 8 per cent to Rs 57 crore for…

May 11, 2023 17:19 IST

Vandana Lal, Vandana Lal journey, Vandana Lal lifestyle, Vandana Lal net worth, Dr Lal PathLabs, Dr Lal PathLabs net worth, Dr Lal PathLabs money, Dr Lal PathLabs covid test, lifestyle

Meet Vandana Lal, Director at Dr Lal PathLabs; Know about her lifestyle, journey, education & more

Dr Lal PathLabs was started in 1949 by the late SK Lal – He was a Junior Doctor in the…

Updated: May 6, 2023 11:15 IST

Pharma stocks, dr lal pathlabs, cipla, covid-19

Pharma, Diagnostics stocks rally amid renewed Covid fears; Dr Lal PathLabs, Cipla shares jump up to 6%

Nifty Pharma index rises 2% as pharma, diagnostics stocks rally amid renewed Covid-19 outbreak fears. Dr Lal PathLabs, Vijaya Diagnostic…

December 21, 2022 13:36 IST

Nifty in short-term downtrend, but these two stocks may help investors pocket gains

The downside target is at 16858 (200 day EMA) once the support of 16958 is broken. We expect buying to…

April 28, 2022 08:18 IST

Vijaya Diagnostic IPO, Vijaya Diagnostic IPO price band

Vijaya Diagnostic Centre IPO opens next week; check grey market premium, price band, lot size, bid details

Vijaya Diagnostic Centre Rs 1,895-crore IPO will open for subscription on 1 September, at a price band of Rs 522-531…

August 26, 2021 11:19 IST

IPO, Vijaya Diagnostic Centre, public issue

Vijaya Diagnostic Centre IPO opens September 1; issue entirely an OFS

Vijaya Diagnostic Centre IPO will open for subscription on 1 September 2021 and close on 3 September.

August 25, 2021 10:55 IST

Krsnaa Diagnostics IPO share allotment: Check status online, grey market premium, listing day strategy

Krsnaa Diagnostics, whose IPO saw 64.40 times subscription, is likely to finalise the share allotment on Thursday, 12 August 2021.

August 12, 2021 11:54 IST

Dr Lal witnessed another quarter of strong growth with 128/41% YoY/QoQ growth.

Analyst Corner: ‘Hold’ on Dr Lal Pathlabs with DCF-based target price of Rs 3,405

However, considering recent rally in the stock price which has made valuations fair, we downgrade it to HOLD from Add.

August 6, 2021 01:00 IST

Krsnaa Diagnostics, IPO, Devyani International, Windlas Biotech, Exxaro Tiles

Krsnaa Diagnostics IPO opens August 4; check price band, grey market premium, IPO size, listing date

Krsnaa Diagnostics Rs 1,213-crore IPO will open for subscription on Wednesday, 4 August 2021, at a price band of Rs…

August 2, 2021 11:22 IST

Adding on to Mishra comments, Dr Lal also said that for the government to reach this magic figure of 2.5% of GDP by 2025, there needs to be additional spend of 1.2 lakh crore on heath every year.

‘To reach 2.5% of GDP spend, healthcare sector does not need a gradual but a quantum jump’

On the slow pace of vaccination Mishra did mention supply bottlenecks, vaccine hesitancy & ability to reach the arm as…

July 16, 2021 17:26 IST

Related News

A viral Reddit post has triggered debate about unpaid pre-shift labour after a line cook alleged that his manager expected him to work 20 minutes each day without pay.

‘I don’t work for free’: Manager demands extra hours without pay, employee says ‘you want me to…’

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Reserve Bank of India has imposed a penalty of Rs 8,43,000 on Union Bank

Reserve Bank imposes a penalty of Rs 8,43,000 on Union Bank

Why millions of Indians now have bloated stomachs

Why millions of Indians now have bloated, protruding stomachs — Dr Eric Berg explains the real cause

New income tax rules coming April 1: 5 major changes for common taxpayers

New income tax rules coming from April 1: 5 major changes for common taxpayers

Reliance Jio IPO likely in H1 of 2026: Valuations to business growth, what we know so far

Market22 min ago

Reliance Industries’ highly anticipated IPO for Jio Platform is expected to launch in the first half of 2026. With a potential valuation of $170 billion, it will be one of the biggest IPOs from the Mukesh Ambani-led group since 2006. Jio’s business growth is evident from its increasing ARPU and subscriber base, making it a lucrative opportunity for investors.

View all shorts

Photo Gallery

Dharmendra passes away at 89: A look back at his iconic roles

3 days agoNovember 24, 2025

View All

Dr Lal Pathlabs

Related News

Photo Gallery

Dharmendra passes away at 89: A look back at his iconic roles

Trending Topics